PHC Holdings Corp. (6523) AI Stock Analysis

• Market Cap: ¥134.07B
• Dividend Yield: 3.73%
• Average Volume (3M): 164.09K
• Price to Earnings (P/E): 28.0
• Beta (1Y): 0.61
• Revenue Growth: 0.04%
• EPS Growth: N/A
• Country: JP
• Employees: 9,245
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): N/A
• Shares Outstanding: 126,724,020
• 10 Day Avg. Volume: 194,380
• 30 Day Avg. Volume: 164,093
• PEG Ratio: -0.07
• Price to Book (P/B): 0.91
• Price to Sales (P/S): 0.36
• P/FCF Ratio: 4.25
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 51 Neutral
• Price Target: ¥1,052.00 ▼(-5.40% Downside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

The score is primarily driven by mixed financial performance: strong recent revenue growth and solid cash flow are offset by thin/volatile profitability and elevated leverage. Technicals are a notable headwind with weak momentum and the price below key moving averages, while valuation is balanced by a high P/E despite an attractive dividend yield.

Positive Factors

Accelerating Revenue Growth

TTM revenue growth of +78% indicates expanding demand and successful product uptake across diabetes, diagnostics and hospital segments. Sustained top-line expansion increases the installed base for consumables and services, drives recurring revenue potential and provides scale for margin and margin-investment improvements over the medium term.

Negative Factors

Thin & Volatile Net Profits

A net margin of about 1.6% coupled with historical swings and losses in FY2022–FY2024 indicates fragile bottom-line conversion. Profit volatility weakens earnings quality and makes cash returns to shareholders and reinvestment plans less predictable, increasing risk if revenue growth slows or costs rise.

PHC Holdings Corp. Business Overview & Revenue Model

Company Description

PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products. The company offers blood glucose monitoring systems and other testing/analysis devic...

Read more

PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products. The company offers blood glucose monitoring systems and other testing/analysis devic...

How the Company Makes Money

PHC Holdings Corp. generates revenue through multiple key streams, primarily from the sale of medical devices and diagnostic products. The company offers a range of products including blood glucose monitoring systems, automated clinical analyzers,...

Read more

PHC Holdings Corp. generates revenue through multiple key streams, primarily from the sale of medical devices and diagnostic products. The company offers a range of products including blood glucose monitoring systems, automated clinical analyzers,...

PHC Holdings Corp. Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	363.93B	361.59B	353.90B	356.43B	340.45B	306.07B
Gross Profit	164.69B	166.22B	157.97B	169.13B	165.24B	143.65B
EBITDA	50.52B	52.33B	30.15B	36.76B	37.56B	62.29B
Net Income	3.54B	10.48B	-12.89B	-3.22B	-8.46B	16.91B
Balance Sheet
Total Assets	552.67B	532.48B	564.33B	561.57B	591.32B	569.35B
Cash, Cash Equivalents and Short-Term Investments	49.03B	43.90B	51.82B	63.25B	97.63B	63.97B
Total Debt	246.45B	269.26B	300.28B	307.24B	323.32B	338.85B
Total Liabilities	394.05B	391.31B	425.16B	422.74B	455.25B	461.78B
Stockholders Equity	159.29B	141.64B	139.51B	138.01B	135.37B	107.02B
Cash Flow
Free Cash Flow	32.03B	30.33B	26.67B	9.86B	39.32B	35.70B
Operating Cash Flow	41.49B	41.94B	41.30B	21.38B	51.05B	47.85B
Investing Cash Flow	-8.05B	-8.47B	-23.68B	-17.52B	-12.52B	-16.31B
Financing Cash Flow	-30.96B	-39.07B	-36.53B	-40.83B	-7.01B	-20.39B

PHC Holdings Corp. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1112.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6523, the sentiment is Positive. The current price of 1112 is above the 20-day moving average (MA) of 1031.65, above the 50-day MA of 1073.66, and above the 200-day MA of 1012.07, indicating a bullish trend. The MACD of -7.47 indicates Negative momentum. The RSI at 62.50 is Neutral, neither overbought nor oversold. The STOCH value of 77.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6523.

PHC Holdings Corp. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6678	78 Outperform	¥20.26B	15.12	―	3.02%	-4.36%	-14.92%
4549	68 Neutral	¥90.07B	26.70	―	2.31%	4.36%	79.43%
7963	67 Neutral	¥9.49B	10.32	―	1.89%	9.47%	37.35%
6849	65 Neutral	¥251.75B	36.37	―	1.92%	4.31%	96.31%
7600	63 Neutral	¥14.25B	14.76	―	3.12%	3.59%	-163.08%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
6523	51 Neutral	¥134.07B	28.05	2.42%	3.73%	0.04%	―